Examkin

Question

Difficulty: HardHemodynamic and Coagulation Processes

A 62-year-old man is evaluated in the hospital for new-onset right leg swelling and pain. He was admitted 8 days ago for a severe exacerbation of chronic obstructive pulmonary disease and has been receiving subcutaneous unfractionated heparin for venous thromboembolism prophylaxis. His platelet count today is 42,000/μL, which represents a significant decline from his admission baseline of 260,000/μL. A lower extremity duplex ultrasound reveals an acute deep vein thrombosis in the right femoral vein. The patient's 4T score indicates a high probability of heparin-induced thrombocytopenia (HIT).

Arrange the following management steps in the correct chronological sequence to appropriately treat this patient's condition and transition him to long-term outpatient therapy.

  1. 1Discontinue the administration of subcutaneous unfractionated heparin
  2. 2Initiate a continuous intravenous infusion of a non-heparin direct thrombin inhibitor
  3. 3Monitor daily until the platelet count recovers to greater than 150,000/μL
  4. 4Initiate oral warfarin therapy while continuing the direct thrombin inhibitor
  5. 5Discontinue the direct thrombin inhibitor once the INR has been therapeutic for at least 48 hours

Answer

The correct sequence is: Discontinue unfractionated heparin -> Initiate a direct thrombin inhibitor -> Wait for platelet recovery -> Initiate warfarin overlap -> Discontinue the direct thrombin inhibitor after therapeutic INR is achieved.
The precise chronological management of HIT with thrombosis requires immediate cessation of the offending agent, prompt alternative anticoagulation to treat the active clot, and a very careful transition to oral anticoagulants. Warfarin is strictly contraindicated until the platelet count normalizes (>150,000/μL) due to the severe risk of venous limb gangrene. Once platelets recover, warfarin can be started but must overlap with the direct thrombin inhibitor for at least 5 days and until the INR is therapeutic for 48 hours.

Step-by-Step Solution

1
Discontinue all heparin exposure immediately.
Halts the ongoing immune-mediated platelet activation by heparin-PF4 complexes.
Continued heparin exposure exacerbates the thrombotic cascade in HIT.
2
Start a non-heparin parenteral anticoagulant (e.g., argatroban, bivalirudin).
Provides immediate therapeutic anticoagulation for the existing deep vein thrombosis.
HIT is highly prothrombotic, and untreated patients have a high risk of life-threatening thrombosis or pulmonary embolism.
3
Delay warfarin initiation until platelets recover to >150,000/μL.
Avoids the transient hypercoagulable state induced by early warfarin administration.
Early warfarin use in acute HIT rapidly depletes Protein C, leading to a severe risk of venous limb gangrene and skin necrosis.
4
Start warfarin with parenteral anticoagulant overlap.
Transitions the patient to long-term oral therapy safely.
Overlap prevents the transient prothrombotic effect of warfarin while waiting for functional depletion of prothrombin (Factor II).
5
Stop the parenteral anticoagulant once the INR is therapeutic for 48 hours.
Completes the transition to monotherapy.
Ensures that all vitamin K-dependent factors, especially Factor II, are adequately depleted before removing parenteral coverage.

Key Concept

Management sequence for Heparin-Induced Thrombocytopenia (HIT) with thrombosis
Rate this question

Topics

Hemodynamic and Coagulation Processes

More questions from this topic